You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
CFSRE recently validated Verogen's NGS-based forensics platform and will develop implementation and training materials for law enforcement.
The law broadens the ability of law enforcement agencies to use rapid DNA sequencing technology and upload resulting data into a federal database.
The Seattle-based firm plans to partner with pharma and biotech to use its duplex sequencing technology in applications such as oncology and forensics.
The researchers plan to commercialize the method, which they said can have applications in both forensics and oncology.
SmallPond is part of a broader collaboration to provide services to the Bermuda police department and to establish a national database of DNA profiles.
Thermo Fisher Scientific has developed forensics panels to run on its S5 sequencing system in anticipation that the forensics market will slowly move from CE to NGS.
New York Genome Center-led researchers have found that short tandem repeats may regulate gene expression rather than representing neutral variation.
The new platform is smaller and less expensive than the company's first-generation forensic DNA platform, processing a single DNA sample in around 70 minutes.
OCME's Department of Forensic Biology recently started testing next-generation sequencing for forensic applications.
Vallone recently authored a review of the field, noting that fully integrated rapid systems have special advantages.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.